154 related articles for article (PubMed ID: 28986753)
21. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging.
Ansciaux E; Burtea C; Laurent S; Crombez D; Nonclercq D; Vander Elst L; Muller RN
Contrast Media Mol Imaging; 2015; 10(3):211-24. PubMed ID: 25284012
[TBL] [Abstract][Full Text] [Related]
23. Biopanning and characterization of peptides with Fe3O4 nanoparticles-binding capability via phage display random peptide library technique.
You F; Yin G; Pu X; Li Y; Hu Y; Huang Z; Liao X; Yao Y; Chen X
Colloids Surf B Biointerfaces; 2016 May; 141():537-545. PubMed ID: 26896661
[TBL] [Abstract][Full Text] [Related]
24. Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer.
Yeh CY; Hsiao JK; Wang YP; Lan CH; Wu HC
Biomaterials; 2016 Aug; 99():1-15. PubMed ID: 27209258
[TBL] [Abstract][Full Text] [Related]
25. Targeting Pancreatic Cancer Cells with Peptide-Functionalized Polymeric Magnetic Nanoparticles.
Zhu X; Lu N; Zhou Y; Xuan S; Zhang J; Giampieri F; Zhang Y; Yang F; Yu R; Battino M; Wang Z
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31248076
[TBL] [Abstract][Full Text] [Related]
26. Specific targeting of angiogenesis in lung cancer with RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a 4.7T magnetic resonance scanner.
Liu C; Liu DB; Long GX; Wang JF; Mei Q; Hu GY; Qiu H; Hu GQ
Chin Med J (Engl); 2013 Jun; 126(12):2242-7. PubMed ID: 23786932
[TBL] [Abstract][Full Text] [Related]
27. Magnetic nanobubbles with potential for targeted drug delivery and trimodal imaging in breast cancer: an in vitro study.
Song W; Luo Y; Zhao Y; Liu X; Zhao J; Luo J; Zhang Q; Ran H; Wang Z; Guo D
Nanomedicine (Lond); 2017 May; 12(9):991-1009. PubMed ID: 28327075
[TBL] [Abstract][Full Text] [Related]
28. An antibody-like peptide that recognizes malignancy among thyroid nodules.
Reis CF; Carneiro AP; Vieira CU; Fujimura PT; Morari EC; Silva SJ; Goulart LR; Ward LS
Cancer Lett; 2013 Jul; 335(2):306-13. PubMed ID: 23462224
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic Value of ER, PR, FR and HER-2-Targeted Molecular Probes for Magnetic Resonance Imaging in Patients with Breast Cancer.
Jin YH; Hua QF; Zheng JJ; Ma XH; Chen TX; Zhang S; Chen B; Dai Q; Zhang XH
Cell Physiol Biochem; 2018; 49(1):271-281. PubMed ID: 30138940
[TBL] [Abstract][Full Text] [Related]
30. Molecular magnetic resonance probe targeting VEGF165: preparation and in vitro and in vivo evaluation.
You XG; Tu R; Peng ML; Bai YJ; Tan M; Li HJ; Guan J; Wen LJ
Contrast Media Mol Imaging; 2014; 9(5):349-54. PubMed ID: 24729581
[TBL] [Abstract][Full Text] [Related]
31. Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives.
Burtea C; Ballet S; Laurent S; Rousseaux O; Dencausse A; Gonzalez W; Port M; Corot C; Vander Elst L; Muller RN
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):e36-48. PubMed ID: 22516067
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of expression of LGALS3BP gene in thyroid tissues and peripheral blood lymphocytes in patients with papillary thyroid cancer].
Kaliszewski K; Łukieńczuk T; Dobosz T; Rzeszutko M; Sadakierska-Chudy A
Endokrynol Pol; 2006; 57 Suppl A():38-44. PubMed ID: 17091455
[TBL] [Abstract][Full Text] [Related]
33. Galectin-3 leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cells.
Harazono Y; Kho DH; Balan V; Nakajima K; Zhang T; Hogan V; Raz A
Oncotarget; 2014 Oct; 5(20):9992-10001. PubMed ID: 25393982
[TBL] [Abstract][Full Text] [Related]
34. Preparation of magnetic resonance probes using one-pot method for detection of hepatocellular carcinoma.
Li YW; Chen ZG; Zhao ZS; Li HL; Wang JC; Zhang ZM
World J Gastroenterol; 2015 Apr; 21(14):4275-83. PubMed ID: 25892879
[TBL] [Abstract][Full Text] [Related]
35. Metformin reduces glycometabolism of papillary thyroid carcinoma in vitro and in vivo.
Shen CT; Wei WJ; Qiu ZL; Song HJ; Zhang XY; Sun ZK; Luo QY
J Mol Endocrinol; 2017 Jan; 58(1):15-23. PubMed ID: 27920093
[TBL] [Abstract][Full Text] [Related]
36. Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma.
Liu YY; Morreau H; Kievit J; Romijn JA; Carrasco N; Smit JW
Eur J Endocrinol; 2008 Mar; 158(3):375-84. PubMed ID: 18299472
[TBL] [Abstract][Full Text] [Related]
37. Ultrasmall Superparamagnetic Iron Oxide Nanoparticles with Europium(III) DO3A as a Bimodal Imaging Probe.
Carron S; Bloemen M; Vander Elst L; Laurent S; Verbiest T; Parac-Vogt TN
Chemistry; 2016 Mar; 22(13):4521-7. PubMed ID: 26880696
[TBL] [Abstract][Full Text] [Related]
38. The expression profiles of the galectin gene family in primary and metastatic papillary thyroid carcinoma with particular emphasis on galectin-1 and galectin-3 expression.
Salajegheh A; Dolan-Evans E; Sullivan E; Irani S; Rahman MA; Vosgha H; Gopalan V; Smith RA; Lam AK
Exp Mol Pathol; 2014 Apr; 96(2):212-8. PubMed ID: 24530443
[TBL] [Abstract][Full Text] [Related]
39. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer.
Ding C; Wu K; Wang W; Guan Z; Wang L; Wang X; Wang R; Liu L; Fan J
Oncotarget; 2017 Jan; 8(3):4718-4729. PubMed ID: 27902468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]